ArticleFrontiers in pharmacology2021

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence.

Yihang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.